从肝硬化到肝发性糖尿病:风险因素和血糖管理
Jing Zhang1, Huipeng Zhang1, Yunqing Zeng1
1Department of Gastroenterology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
肝发性糖尿病 (HD) 与长期肝硬化,乙型肝炎传播,高Child-Pugh等级和高甘油三有关. 与单独服用口服药物相比,胰岛素治疗显著改善了HD患者的血糖控制.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 内分泌学 在内分泌学.
- 胃肠病学 胃肠病学
背景情况:
- 肝炎性糖尿病 (HD) 是一种复杂的疾病,是肝脏疾病的次要症状.
- 了解HD的风险因素和最佳管理对于患者的治疗结果至关重要.
研究的目的:
- 为了确定肝发性糖尿病发展的独立风险因素.
- 在HD患者中比较不同降血糖治疗方式的有效性.
主要方法:
- 一项多中心研究涉及327名HD患者和329名非糖尿病肝硬化 (LC) 对照.
- 用逻辑回归分析对HD的风险因素的分析.
- 在HD患者的三个治疗组中,血糖控制 (HbA1c) 的比较.
主要成果:
- 延长LC持续时间 (OR=1.111),垂直乙型肝炎传播 (OR=2.254),高Child-Pugh等级 (OR=1.566),和高甘油三 (OR=2.695) 是疾病发病的重要危险因素.
- 内镜治疗史显示有保护作用 (OR=0.615).
- 与单独服用口服药物相比,单独或与口服药物联合使用胰岛素治疗显示出更好的血糖控制 (p<0.05).
结论:
- 疾病的关键风险因素包括晚期肝病,病毒性肝炎传播和代谢失调.
- 内镜治疗可能提供一种保护性益处,防止HD的发展.
- 基于胰岛素的疗法在治疗肝炎性糖尿病的高血糖症方面更有效.
更多相关视频
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
08:13Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Hypoglycemia and Glucagon
Diabetes: Symptoms, Diagnosis, and Complications
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
